Dillan is an Associate in the Corporate and Life Sciences group in London. He specialises in advising companies and investors in the technology and life sciences sector on venture capital investments, M&A transactions and general corporate matters.
Adoption of Commission Implementing Regulation (EU) 2025/2086: New Rules on the Joint Clinical Assessment of Medical Devices and In Vitro Diagnostic Medical Devices
